NCT05974410 2025-10-02Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer PatientsAVM Biotechnology IncAvailable
NCT05476770 2024-12-06Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesTherapeutic Advances in Childhood Leukemia ConsortiumPhase 1 Recruiting54 enrolled
NCT00185692 2019-12-04Allogeneic Transplantation From Related Haploidentical DonorsStanford UniversityPhase 2 Completed16 enrolled 8 charts
NCT00002552 2013-04-09Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple MyelomaBarbara Ann Karmanos Cancer InstitutePhase 2 Completed40 enrolled